Products

Comprehensive catalog of pharmaceutical solutions. Browse categories and send inquiries directly.

Connect With Us

All Products (361)

Quick filters: Solid Tumour Hematologic Both Name A-Z Name Z-A

Therapeutic Areas

Sort by

Clear all filters

Molecule	Drug Class / Mechanism	Oncology Type
Lenograstim	G-CSF / GM-CSF Analogue	Both (Solid & Hematologic)
Molecule Lenograstim Therapeutic Category Supportive Care (Growth Factor) Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism G-CSF / GM-CSF Analogue
Balugrastim	G-CSF / GM-CSF Analogue	Both (Solid & Hematologic)
Molecule Balugrastim Therapeutic Category Supportive Care (Growth Factor) Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism G-CSF / GM-CSF Analogue
Efbemalenograstim Alfa	G-CSF / GM-CSF Analogue	Both (Solid & Hematologic)
Molecule Efbemalenograstim Alfa Therapeutic Category Supportive Care (Growth Factor) Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism G-CSF / GM-CSF Analogue
Ropeginterferon Alfa-2b	G-CSF / GM-CSF Analogue	Both (Solid & Hematologic)
Molecule Ropeginterferon Alfa-2b Therapeutic Category Supportive Care (Growth Factor) Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism G-CSF / GM-CSF Analogue
Zoledronic Acid	Bisphosphonate	Both (Solid & Hematologic)
Molecule Zoledronic Acid Therapeutic Category Bone-Modifying Agent Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism Bisphosphonate
Pamidronate Disodium	Bisphosphonate	Both (Solid & Hematologic)
Molecule Pamidronate Disodium Therapeutic Category Bone-Modifying Agent Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism Bisphosphonate
Ibandronate Sodium	Bisphosphonate	Both (Solid & Hematologic)
Molecule Ibandronate Sodium Therapeutic Category Bone-Modifying Agent Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism Bisphosphonate
Clodronate Disodium	Bisphosphonate	Both (Solid & Hematologic)
Molecule Clodronate Disodium Therapeutic Category Bone-Modifying Agent Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism Bisphosphonate
Alendronate (Onc Adjacent)	Bisphosphonate	Both (Solid & Hematologic)
Molecule Alendronate (Onc Adjacent) Therapeutic Category Bone-Modifying Agent Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism Bisphosphonate
Risedronate (Onc Adjacent)	Bisphosphonate	Both (Solid & Hematologic)
Molecule Risedronate (Onc Adjacent) Therapeutic Category Bone-Modifying Agent Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism Bisphosphonate
Etidronate	Bisphosphonate	Both (Solid & Hematologic)
Molecule Etidronate Therapeutic Category Bone-Modifying Agent Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism Bisphosphonate
Ondansetron	5-HT3 Receptor Antagonist	Both (Solid & Hematologic)
Molecule Ondansetron Therapeutic Category Supportive Care (Antiemetic) Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism 5-HT3 Receptor Antagonist

Lenograstim Supportive Care (Growth Factor)
Therapeutic Category Supportive Care (Growth Factor) Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism G-CSF / GM-CSF Analogue
Balugrastim Supportive Care (Growth Factor)
Therapeutic Category Supportive Care (Growth Factor) Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism G-CSF / GM-CSF Analogue
Efbemalenograstim Alfa Supportive Care (Growth Factor)
Therapeutic Category Supportive Care (Growth Factor) Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism G-CSF / GM-CSF Analogue
Ropeginterferon Alfa-2b Supportive Care (Growth Factor)
Therapeutic Category Supportive Care (Growth Factor) Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism G-CSF / GM-CSF Analogue
Zoledronic Acid Bone-Modifying Agent
Therapeutic Category Bone-Modifying Agent Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism Bisphosphonate
Pamidronate Disodium Bone-Modifying Agent
Therapeutic Category Bone-Modifying Agent Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism Bisphosphonate
Ibandronate Sodium Bone-Modifying Agent
Therapeutic Category Bone-Modifying Agent Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism Bisphosphonate
Clodronate Disodium Bone-Modifying Agent
Therapeutic Category Bone-Modifying Agent Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism Bisphosphonate
Alendronate (Onc Adjacent) Bone-Modifying Agent
Therapeutic Category Bone-Modifying Agent Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism Bisphosphonate
Risedronate (Onc Adjacent) Bone-Modifying Agent
Therapeutic Category Bone-Modifying Agent Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism Bisphosphonate
Etidronate Bone-Modifying Agent
Therapeutic Category Bone-Modifying Agent Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism Bisphosphonate
Ondansetron Supportive Care (Antiemetic)
Therapeutic Category Supportive Care (Antiemetic) Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism 5-HT3 Receptor Antagonist

‹ 1 … 17 18 19 20 21 … 31 ›

Product Range

Company

Global Network

Products

Lenograstim

Balugrastim

Efbemalenograstim Alfa

Ropeginterferon Alfa-2b

Zoledronic Acid

Pamidronate Disodium

Ibandronate Sodium

Clodronate Disodium

Alendronate (Onc Adjacent)

Risedronate (Onc Adjacent)

Etidronate

Ondansetron

Lenograstim

Balugrastim

Efbemalenograstim Alfa

Ropeginterferon Alfa-2b

Zoledronic Acid

Pamidronate Disodium

Ibandronate Sodium

Clodronate Disodium

Alendronate (Onc Adjacent)

Risedronate (Onc Adjacent)

Etidronate

Ondansetron